Senior insider sale
Chief Executive Officer at BELITE BIO, INC — senior position signals high conviction
$24.31M
136K shares
What this filing means
LIN YU-HSIN plans to sell 136K shares of BELITE BIO, INC valued at approximately $24.31M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/9/2026ACC: 0001968582-26-000356
DirectorOfficer· Chief Executive Officer
Since Mar 2026
136K
Shares to sell
$24.31M
Approx. market value
136K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months7
RSU Vesting
N/A
11/3/2025
20KRSU Vesting
N/A
10/17/2025
20KRSU Vesting
N/A
9/16/2025
18.78KESOP Exercise
Cash
3/12/2025
11.39KESOP Exercise
Cash
3/11/2025
7.91KESOP Exercise
Cash
3/6/2025
15.11KESOP Exercise
Cash
2/27/2025
42.81KTotal acquired136K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/3/2025 | RSU Vesting N/A | 20K | — |
10/17/2025 | RSU Vesting N/A | 20K | — |
9/16/2025 | RSU Vesting N/A | 18.78K | — |
3/12/2025 | ESOP Exercise Cash | 11.39K | — |
3/11/2025 | ESOP Exercise Cash | 7.91K | — |
3/6/2025 | ESOP Exercise Cash | 15.11K | — |
2/27/2025 | ESOP Exercise Cash | 42.81K | — |
| Total | 136K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
136K
Market value
$24.31M
4/9/2026
Total
Units
136K
Value
$24.31M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
4/9/2026 | 136K | $24.31M | NASDAQ | Planned |
| Total | 136K | $24.31M | ||